Join to View Full Profile
177 E Brush Hill RdElmhurst, IL 60126
Phone+1 630-646-2273
Dr. Wiele is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2018 - 2020
Indiana University School of MedicineResidency, Internal Medicine, 2014 - 2017
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2014
Certifications & Licensure
IL State License 2021 - 2026
TX State License 2020 - 2022
IN State License 2017 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsTreatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, Tharakeswara K Bathala, Andrew J Wiele
The Oncologist. 2024-05-03 - 7 citationsCytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.Andrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, Alberto C Pieretti, Andrew J Wiele
European Urology Focus. 2023-09-01 - 20 citationsEfficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinomaNathaniel R. Wilson, Andrew James Wiele, Devaki Shilpa Surasi, Priya Rao, Kanishka Sircar
Clinical Genitourinary Cancer. 2021-09-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
